Frontal Lobe Degeneration in Adults with Down Syndrome and Alzheimer's Disease: A Review

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Dementia and Geriatric Cognitive Disorders

• Publication date

  2016-02-19

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000442941PMID 26891227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions

  2015cited by this paper
• Functional abilities and cognitive decline in adult and aging intellectual disabilities. Psychometric validation of an Italian version of the Alzheimer's Functional Assessment Tool (AFAST): analysis of its clinical significance with linear statistics and artificial neural networks.

  2015cited by this paper
• Differences in age-related effects on brain volume in Down syndrome as compared to Williams syndrome and typical development

  2014cited by this paper
• A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.

  2014cited by this paper
• Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome

  2014cited by this paper
• Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

  2014cited by this paper
• Progressive myoclonus epilepsy in Down syndrome patients with dementia

  2014cited by this paper
• Ageing and dementia in a longitudinal study of a cohort with Down syndrome.

  2014cited by this paper
• Adaptación y validación del Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS) en población española con discapacidad intelectual

  2013cited by this paper
• A systematic review on assessment instruments for dementia in persons with intellectual disabilities.

  2013cited by this paper
• Atypical aging in Down syndrome.

  2013cited by this paper
• [Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities].

  2013cited by this paper
• Down Syndrome and Dementia: Seizures and Cognitive Decline

  2012cited by this paper
• Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

  2012cited by this paper
• Variants in CYP17 and CYP19 Cytochrome P450 Genes are Associated with Onset of Alzheimer's Disease in Women with Down Syndrome

  2012cited by this paper
• Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• Oxidative Stress and Memory Decline in Adults with Down Syndrome: Longitudinal Study

  2012cited by this paper
• Further Evaluation of the Criterion Validity of the Severe Impairment Battery for the Assessment of Cognitive Functioning in Adults with Down Syndrome.

  2011cited by this paper
• Plasma Amyloid-β as a Function of Age, Level of Intellectual Disability, and Presence of Dementia in Down Syndrome

  2011cited by this paper
• Behavioural Excesses and Deficits Associated with Dementia in Adults who have Down Syndrome

  2011cited by this paper
• TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

  2011cited by this paper
• Supporting persons with intellectual disability and dementia: quality dementia care standards. A guide to practice

  2010cited by this paper
• Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer's disease in people with Down's syndrome: potential involvement of multiple frontal-subcortical neuronal circuits.

  2010cited by this paper
• Relationships amongst age, language and related skills in adults with Down syndrome.

  2010cited by this paper
• The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome.

  2010cited by this paper
• Change in plasma Aβ peptides and onset of dementia in adults with Down syndrome

  2010cited by this paper
• Neuroimaging of individuals with Down's syndrome at-risk for dementia: Evidence for possible compensatory events

  2008cited by this paper
• Diagnostic Manual–Intellectual Disability: A Textbook of Diagnosis of Mental Disorders in Persons With Intellectual Disability

  2008cited by this paper
• Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.

  2007cited by this paper
• The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.

  2007cited by this paper
• Epidemiology of Down syndrome.

  2007cited by this paper
• Cognitive executive function in Down's syndrome.

  2006cited by this paper
• Healthy ageing in people with Down syndrome and dementia: The need to foster education and support programs for individuals, families and organizations

  2006cited by this paper
• Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population‐based study

  2006cited by this paper
• The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.

  2004cited by this paper
• Dementia in adults with mental retardation: assessment at a single point in time.

  2004cited by this paper
• Down's syndrome.

  2003cited by this paper
• Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies.

  2002cited by this paper
• Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.

  2001cited by this paper
• Neurological changes and emotional functioning in adults with Down Syndrome.

  2001cited by this paper
• Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

  2000cited by this paper
• Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs.

  2000cited by this paper
• First Symptoms – Frontotemporal Dementia versus Alzheimer’s Disease

  2000cited by this paper
• Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s disease

  2000cited by this paper
• A four year prospective study of age-related cognitive change in adults with Down's syndrome

  1998cited by this paper
• Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.

  1995cited by this paper
• Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates

  1995cited by this paper
• Callosal morphology concurs with neurobehavioral and neuropathological findings in two neurodevelopmental disorders.

  1992cited by this paper
• Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome

  1985cited by this paper
• Down's syndrome

  1974cited by this paper

• Evaluation of [18F]MK-6240 binding to tau protein in postmortem human brains of Down syndrome and Alzheimer’s disease and assessment of off-target (non-tau) binding

  2026cites this paper
• Spatial abilities in aging adults with Down syndrome

  2026cites this paper
• Frontal Disorders and Consciousness: A Review

  2025cites this paper
• Symptoms and age of prodromal Alzheimer’s disease in Down syndrome: a systematic review and meta-analysis

  2024cites this paper
• Therapeutic Targets and Natural Product Screening for Cognitive Impairments Associated with Ferroptosis in Wilson's Disease.

  2024cites this paper
• A novel dual-branch Alzheimer’s disease diagnostic model based on distinguishing atrophic patch localization

  2024cites this paper
• From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach

  2024cites this paper
• Ferulic Acid Activates SIRT1-Mediated Ferroptosis Signaling Pathway to Improve Cognition Dysfunction in Wilson’s Disease

  2023cites this paper
• Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

  2023cites this paper
• Structural Connectivity in Down Syndrome and Alzheimer’s Disease

  2022cites this paper
• Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos

  2022cites this paper
• Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome

  2022cites this paper
• Cognitive assessment using the Rapid Assessment for Developmental Disabilities, Second Edition (RADD-2).

  2021cites this paper
• Mental Health, Intellectual and Developmental Disabilities and the Ageing Process

  2021cites this paper
• Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models

  2021cites this paper
• Sintomas depressivos e pré-frontais em idosos institucionalizados e não institucionalizados

  2021cites this paper
• The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease

  2021cites this paper
• Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component

  2020cites this paper
• Neurocognitive Disorders Assessments

  2020cites this paper
• Validity Evidences of the Prefrontal Symptoms Inventory for the Elderly Brazilian Population

  2020cites this paper
• Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue

  2020cites this paper
• Amnestic and non‐amnestic symptoms of dementia: An international study of Alzheimer's disease in people with Down's syndrome

  2020cites this paper
• A Novel Framework to Measure Executive Function in Down Syndrome With Applications for Early Clinical Diagnosis of Dementia.

  2019cites this paper
• Early alterations in cortical and cerebellar regional brain growth in Down Syndrome: An in vivo fetal and neonatal MRI assessment

  2019cites this paper
• Early alterations in cortical and cerebellar regional brain growth in Down Syndrome: An in vivo fetal and neonatal MRI assessment

  2019cites this paper
• Microstate Changes Associated With Alzheimer’s Disease in Persons With Down Syndrome

  2019cites this paper
• Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome.

  2019cites this paper
• Exosome release and cargo in Down syndrome

  2019cites this paper
• EXECUTIVE FUNCTION IN DOWN SYNDROME : A META-ANALYSIS by ANDREW TUNGATE FRANCES CONNERS , COMMITTEE CHAIR

  2018cites this paper
• The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil

  2018cites this paper
• The Severe Impairment Battery

  2018cites this paper
• A Multicentre Italian Validation Study in Aging Adults with Down Syndrome and Other Forms of Intellectual Disabilities: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities.

  2017cites this paper
• Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome☆

  2017cites this paper